ClinicalTrials.gg

Program

VV261

A development code. Also written as “VV261 5mg group”, “VV261 600mg TID group” and “VV261 900mg TID group”.

Its studies are led by Vigonvita Life Sciences.

Furthest: phase 1, since Dec 11, 20253 company-led studies, 2 open or runningNext primary completion: Nov 30, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Vigonvita Life Sciences32 open or runningphase 1since Dec 11, 2025Dec 11, 2025Nov 30, 2026phase 1 · NCT07710326

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 11, 2025First study: phase 1 study in Healthy VolunteersFirst studyNCT07302269 · 66 enrolled · China
  2. Jul 13, 2026Phase 1 study in Healthy VolunteersNCT07710326 · 16 planned · China
  3. Nov 4, 2026Phase 1 study in Severe Fever with Thrombocytopenia SyndromeNCT07927218 · 15 planned · China

Ahead

  1. Nov 30, 2026Primary completion: phase 1 study in Healthy VolunteersNCT07710326
  2. Dec 30, 2026Primary completion: phase 1 study in Severe Fever with Thrombocytopenia SyndromeNCT07927218

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07927218Severe Fever with Thrombocytopenia Syndrome · China1Not yet recruitingDec 30, 202615
NCT07710326Healthy Volunteers · China1RecruitingNov 30, 202616
NCT07302269Healthy Volunteers · China1CompletedAug 19, 202666

How it is read

Names in the registry

  • “VV261”, 3 entries
  • “VV261 5mg group”, 1 entry
  • “VV261 600mg TID group”, 1 entry
  • “VV261 900mg TID group”, 1 entry

Codes read as this program: VV261.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.